Literature DB >> 19995551

Hsp104 is essential for the selective degradation in yeast of polyglutamine expanded ataxin-1 but not most misfolded proteins generally.

Do Hee Lee1, Alfred L Goldberg.   

Abstract

Molecular chaperones of the Hsp70/40 family protect against the accumulation of mutated or misfolded proteins in part by facilitating their degradation. In the polyglutamine (polyQ) diseases, mutant proteins containing expanded polyQ repeats accumulate in intracellular inclusions and cause neurodegeneration. Although the ubiquitin-proteasome system and chaperones all help protect against accumulation of such toxic proteins, their precise roles are still unclear. Here we observed that the polyQ-expanded mutant ataxin-1 [82Q] was rapidly and selectively degraded in yeast while the wild-type protein [30Q] was stable. The selective degradation of the mutant ataxin-1 required proteasomes, but did not require Ydj1p, an Hsp40 homolog, which is involved in the disaggregation and/or breakdown of a number of misfolded proteins. However, another chaperone Hsp104 promoted degradation of mutant ataxin-1 without influencing the solubility or breakdown of short-lived cell proteins generally. Thus Hsp104-dependent degradation of mutant ataxin-1 may account for the ability of this chaperone to reduce toxicity caused by polyQ-repeat proteins. Copyright 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995551      PMCID: PMC3779135          DOI: 10.1016/j.bbrc.2009.12.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Posttranslational quality control: folding, refolding, and degrading proteins.

Authors:  S Wickner; M R Maurizi; S Gottesman
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

Review 2.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

3.  Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast.

Authors:  Y Zhang; G Nijbroek; M L Sullivan; A A McCracken; S C Watkins; S Michaelis; J L Brodsky
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

Authors:  C J Cummings; E Reinstein; Y Sun; B Antalffy; Y Jiang; A Ciechanover; H T Orr; A L Beaudet; H Y Zoghbi
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

5.  Degradation of unassembled Vph1p reveals novel aspects of the yeast ER quality control system.

Authors:  K Hill; A A Cooper
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

6.  Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.

Authors:  S Krobitsch; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans.

Authors:  S H Satyal; E Schmidt; K Kitagawa; N Sondheimer; S Lindquist; J M Kramer; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.

Authors:  Christine K Bailey; Isabella F M Andriola; Harm H Kampinga; Diane E Merry
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

Review 9.  Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.

Authors:  Hideki Sakahira; Peter Breuer; Manajit K Hayer-Hartl; F Ulrich Hartl
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

10.  Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Xiangwei He; Gary P Newnam; Yury O Chernoff; Michael Y Sherman
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  9 in total

Review 1.  Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.

Authors:  James Shorter; Daniel R Southworth
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

2.  Hsp104 facilitates the endoplasmic-reticulum-associated degradation of disease-associated and aggregation-prone substrates.

Authors:  Lynley M Doonan; Christopher J Guerriero; G Michael Preston; Teresa M Buck; Netaly Khazanov; Edward A Fisher; Hanoch Senderowitz; Jeffrey L Brodsky
Journal:  Protein Sci       Date:  2019-05-20       Impact factor: 6.725

3.  Hsp70 targets a cytoplasmic quality control substrate to the San1p ubiquitin ligase.

Authors:  Christopher J Guerriero; Kurt F Weiberth; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

4.  Hsp104 and Potentiated Variants Can Operate as Distinct Nonprocessive Translocases.

Authors:  Clarissa L Durie; JiaBei Lin; Nathaniel W Scull; Korrie L Mack; Meredith E Jackrel; Elizabeth A Sweeny; Laura M Castellano; James Shorter; Aaron L Lucius
Journal:  Biophys J       Date:  2019-04-05       Impact factor: 4.033

5.  Insight into molecular basis of curing of [PSI+] prion by overexpression of 104-kDa heat shock protein (Hsp104).

Authors:  Christopher W Helsen; John R Glover
Journal:  J Biol Chem       Date:  2011-11-11       Impact factor: 5.157

Review 6.  AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.

Authors:  Zachary M March; Korrie L Mack; James Shorter
Journal:  Biophys J       Date:  2019-03-22       Impact factor: 4.033

Review 7.  The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Proteostasis Factors.

Authors:  Benjamin C Creekmore; Yi-Wei Chang; Edward B Lee
Journal:  J Neuropathol Exp Neurol       Date:  2021-06-04       Impact factor: 3.685

Review 8.  Studying Huntington's Disease in Yeast: From Mechanisms to Pharmacological Approaches.

Authors:  Sebastian Hofer; Katharina Kainz; Andreas Zimmermann; Maria A Bauer; Tobias Pendl; Michael Poglitsch; Frank Madeo; Didac Carmona-Gutierrez
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 6.261

9.  Distinct classes of misfolded proteins differentially affect the growth of yeast compromised for proteasome function.

Authors:  Grace D Burns; Olivia E Hilal; Zhihao Sun; Karl-Richard Reutter; G Michael Preston; Andrew A Augustine; Jeffrey L Brodsky; Christopher J Guerriero
Journal:  FEBS Lett       Date:  2021-08-17       Impact factor: 3.864

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.